Inventor
BRAVO GONZÁLEZ ROBERTO CARLOS
CH10 patents
⚠️ This page may combine multiple inventors who share the name “BRAVO GONZÁLEZ ROBERTO CARLOS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TILLOTTS PHARMA AG
6 patentsUS10272048B2Apr 30, 2019
Delayed release drug formulation
TILLOTTS PHARMA AG4 citations82
US9814681B2Nov 14, 2017
Delayed release drug formulation
TILLOTTS PHARMA AG6 citations82
US11534406B2Dec 27, 2022
Delayed release drug formulation
TILLOTTS PHARMA AG3 citations71
US11517534B2Dec 6, 2022
Delayed release drug formulation
TILLOTTS PHARMA AG2 citations71
US12370147B2Jul 29, 2025
Coatable core for a modified release drug formulation
TILLOTTS PHARMA AG0 citations55
US12370146B2Jul 29, 2025
Method of producing a delayed release drug formulation
TILLOTTS PHARMA AG0 citations49
CANCER PREVENTION PHARMACEUTICALS INC
4 patentsUS11529326B2Dec 20, 2022
Eflornithine and sulindac, fixed dose combination formulation
CANCER PREVENTION PHARMACEUTICALS INC1 citations68
US12350246B2Jul 8, 2025
Eflornithine and sulindac, fixed dose combination formulation
CANCER PREVENTION PHARMACEUTICALS INC0 citations57
US11925613B2Mar 12, 2024
Eflornithine and sulindac, fixed dose combination formulation
CANCER PREVENTION PHARMACEUTICALS INC0 citations57
US10973790B2Apr 13, 2021
Eflornithine and sulindac, fixed dose combination formulation
CANCER PREVENTION PHARMACEUTICALS INC0 citations57